PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 7, 1998, Pages 684-689

  Tohma, Yasuo ^a   Gratas, Catherine ^a   Biernat, Wojciech ^a   Peraud, Aurelia ^a   Fukuda, Masakatsu ^a   Yonekawa, Yasuhiro ^b   Kleihues, Paul ^b   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

MMAC1; Mutation; Primary gtioblastoma; PTEN; Secondary glioblastoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE INSERTION; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MUTATION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0031840405     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199807000-00005     Document Type: Article

References (33)

1. Albarosa R, Colombo BM, Roz L, et al. Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am J Hum Genet 1996;58:1260-67
2. Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994;81:427-36
3. Fults D, Pedone C. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosom Cancer 1993;7:173-77
4. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-26
5. Rasheed BK, McLendon RE, Friedman HS, et al. Chromosome 10 deletion mapping in human gliomas: A common deletion region in 10q25. Oncogene 1995;10:2243-46
6. Louis DN. A molecular genetic model of astrocytoma histopathology. Brain Pathol 1997;7:755-64
7. Sonoda Y, Murakami Y, Tominaga T, Kayama T, Yoshimoto T, Sekiya T. Deletion mapping of chromosome 10 in human glioma. Jpn J Cancer Res 1996;87:363-67
8. Steck PA, Ligon AH, Cheong P, Yung WK, Pershouse MA. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer 1995;12:255-61
9. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-47
10. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 1997; 15:356-62
11. 1. Cancer Res 1998;58:29-33
12. Wang SI, Pue J, Li J, et al. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997;57:4183-86
13. Rasheed BKA, Stenzel TT, McLendon RE, et al. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 1997;57:4187-90
14. Duerr E-M, Rollbrocker B, Hayashi Y, et al. PTEN mutations in gliomas and glioneuronal tumors. Oncogene 1998. Forthcoming.
15. Liu W, James CD, Frederick L, Alderete BE, Jenkins RB. PTEN/ MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 1997;57:5254-57
16. Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues R Ohgaki H. p53 and PTEN gene mutations in gemistocytic astrocytomas. Acta Neuropath 1998. Forthcoming.
17. Scherer HJ. Cerebral astrocytomas and their derivatives. Am J Cancer 1940;40:159-98
18. Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system. 5th ed. London: Edward Arnold; 1989
19. Burger PC, Scheithauer BW. Tumors of the central nervous system. Washington: Armed Forces Institute of Pathology, 1994
20. Kleihues P, Burger PC, Plate KH, Ohgaki H, Cavenee WK. Glioblastoma. In: Kleihues P, Cavenee WK, eds. Pathology and genetics. Tumours of the nervous system. Lyon: International Agency for Research on Cancer, 1997;1:16-24
21. Lantos PL, VandenBerg SR, Kleihues P. Tumours of the nervous system. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology. 6th ed. London: Edward Arnold; 1996;9:583-79
22. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996;6:217-24
23. Biernat W, Kleihues P, Yonekawa Y, Ohgaki H. Amplification and Overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol 1996;56:180-85
24. Biernat W, Tohma Y, Yonekawa Y, Kleihues P, Ohgaki H. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas. Acta Neuropathol 1997;94:303-9
25. Hunter SB, Abbott K, Varma VA, Olson JJ, Barnett DW, James CD. Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. J Neuropathol Exp Neurol 1995;54:57-64
26. Rollbrocker B, Waha A, Louis DN, Wiestler OD, von Deimling A. Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme. Acta Neuropathol 1996;92:70-74
27. Myers MP, Stolarov JP, Eng C, et al. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 1997;94:9052-57
28. Chuang JZ, Lin DC, Lin S. Molecular cloning, expression, and mapping of the high affinity actin-capping domain of chicken cardiac tensin. J Cell Biol 1995;128:1095-1109
29. Miyamoto S, Teramoto H, Coso OA, et al. Integrin function: Molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 1995;131:791-805
30. Miyamoto S, Akiyama SK, Yamada KM. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 1995;267:883-85
31. von Deimling A, Louis DN, von Ammon K, et al. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 1992;77:295-301
32. Mollenhauer J, Wiemann S, Scheurlen W, et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 1997;17:32-39
33. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 1992;52: 674-79